Covid-19: Delhi has only one day's Covaxin stock left, says Satyendar Jain

Health Minister Satyendar Jain on Monday said Delhi has only one day's Covaxin stock left and its Covishield doses will last for just three to four days

Satyendar Jain | Photo: ANI
Satyendar Jain | Photo: ANI
Press Trust of India New Delhi
2 min read Last Updated : May 10 2021 | 4:01 PM IST

Health Minister Satyendar Jain on Monday said Delhi has only one day's Covaxin stock left and its Covishield doses will last for just three to four days.

The minister's remarks came a day after Chief Minister Arvind Kejriwal urged the Centre to direct manufacturers to increase vaccine supplies to the capital between May and July.

"Covaxin doses can last up to one day only, while Covishield doses can last up to three to four days," Jain told reporters after reviewing preparations at Guru Teg Bahadur COVID Care Centre at Gurdwara Rakab Ganj Sahib in central Delhi.

Delhi has so far received 5.5 lakh doses of coronavirus vaccines for the 18-44 category, and over 43 lakh doses for 45-plus, and healthcare and frontline workers, according to government data released on Sunday.

Around 39 lakh doses have been administered in the national capital so far.

Till Sunday evening, Delhi had 4.65 lakh doses of coronavirus vaccines available for those above 45, and healthcare and frontline workers, while 2.74 lakh doses were available for the 18-44 age category.

The health minister said the dip in the positivity rate and the number of new infections over the last fortnight is a "glimmer of hope".

"The number of cases has reduced from around 28,000 to 13,000 now. The positivity rate has come down from a high of 36 per cent to around 20 per cent," Jain said.

He, however, said there's no room for any leniency and urged everyone to keep their guard up.

Jain said the 400-bed Guru Teg Bahadur COVID Care Centre has been attached with the Delhi government-run Lok Nayak Jai Prakash Narayan Hospital.

The Delhi Sikh Gurdwara Management Committee has provided the infrastructure for the facility and the Delhi government has given medical support, he said.

Manjinder Singh Sirsa, president of the DSGMC, said the COVID care centre will be managed by 50 doctors from LNJP Hospital. They will be supported by a team of 150 nurses and ward boys.

All beds have oxygen concentrators. The facility has a backup of 150 D-type cylinders. It has all the essential drugs, including Remdesivir and Fabiflu, used in the treatment of COVID-19, Sirsa said.

"Patients who need up to 20 litres per minute of oxygen can be treated here," he said, adding that the treatment and food will be completely free.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusSatyendar JainCoronavirus TestsCoronavirus Vaccine

First Published: May 10 2021 | 4:00 PM IST

Next Story